SUBSCRIBE
SUBSCRIBE
News   Drug Development

Roche Holding Cancer Drug Trial Succeeds Two Years Early

October 19, 2005 | 
1 min read
A late-stage clinical trial of cancer drug MabThera for treating the relapsed indolent form of non-Hodgkin's lymphoma met its primary goals two years earlier than expected, Roche Holding AG (ROG.VX: Quote, Profile, Research) said on Tuesday.
Clinical research Phase III
MORE ON THIS TOPIC
Conceptual business illustration of upcoming business problem metaphor with falling domino and businessman silhouette. Minimalistic vector eps 10 illustration
Inflammatory bowel disease
CytomX Reports Treatment-Related Patient Death in Phase I Colorectal Cancer Study
August 14, 2025
 · 
2 min read
 · 
Tristan Manalac
cutting off a row of people into pieces
Layoffs
Vedanta Downsizes by 20% After Phase II Stumble in Ulcerative Colitis
August 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Retro collage hand holding pie chart diagram. Business data and market share concept. Modern retro grunge. Vector illustration
Gene therapy
Sarepta Provides New Elevidys Safety Data, Reveals Zero Ambulatory Deaths
August 13, 2025
 · 
2 min read
 · 
Tristan Manalac
The female hand is showing a thumbs-up gesture on a pink background, in an art collage. Positive hand sign. Fashion collage in the style of thumbs up magazine. Contemporary art. Modern design.
Lung cancer
140-Year-Old Boehringer Ingelheim Dives Into Cancer With NSCLC Nod
August 11, 2025
 · 
2 min read
 · 
Tristan Manalac